Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma

Renal-cell carcinoma (RCC) remains a leading cause of cancer-related mortality worldwide. Though newer therapeutic combinations of immune checkpoint inhibitors and targeted therapies have greatly improved outcomes, resistance to these therapies is becoming a challenge for long-term control. Mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatwal, Monica Sheila, Chahoud, Jad, Spiess, Philippe E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344725/
https://www.ncbi.nlm.nih.gov/pubmed/37457132
http://dx.doi.org/10.20517/cdr.2023.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344725/
https://www.ncbi.nlm.nih.gov/pubmed/37457132
http://dx.doi.org/10.20517/cdr.2023.09

Ejemplares similares